1-4 of 4
Robert L Capizzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

Harry P Erba, Margaret O'Donnell, Steven L Allen, Maria R Baer, Bayard L Powell, Richard M Stone, John M Bennett, Ante S Lundberg, Robert L Capizzi, David A Rizzieri
Journal: Blood
Blood (2009) 114 (22): 1047.
https://doi.org/10.1182/blood.V114.22.1047.1047
Published: 2009
Journal Articles

Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML

Steven L Allen, Harry P Erba, David A. Rizzieri, Margaret O’Donnell, Bayard Powell, Ante S Lundberg, John M Bennett, Robert L Capizzi
Journal: Blood
Blood (2008) 112 (11): 2968.
https://doi.org/10.1182/blood.V112.11.2968.2968
Published: 2008
Journal Articles

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I 131 tositumomab

Clinical Trials & Observations
John M. Bennett, Mark S. Kaminski, John P. Leonard, Julie M. Vose, Andrew D. Zelenetz, Susan J. Knox, Sandra Horning, Oliver W. Press, John A. Radford, Stewart M. Kroll, Robert L. Capizzi
Journal: Blood
Blood (2005) 105 (12): 4576–4582.
https://doi.org/10.1182/blood-2004-12-4690
Published: 2005
Journal Articles

A Novel N-Oxide Drug, AQ4N, Has In Vitro Activity in Lymphoma and Leukemia Cell Lines and Selectively Targets Lymphocytes and Lymphatic Tissues in Vivo.

Jeffrey L. Cleland, Ph.D., Alvin Wong, Pharm.D., Susan E. Alters, Ph.D., Peter A. Harris, M.D., Chris R. Dunk, B.S., John G. Curd, M.D., Robert L. Capizzi, M.D., William D. Henner, M.D.
Journal: Blood
Blood (2004) 104 (11): 2498.
https://doi.org/10.1182/blood.V104.11.2498.2498
Published: 2004